Health Security · 17 Nov 2026
Securing Cell-Free Expression: Safeguards for Distributed Biomanufacturing
Liyam Chitayat, Sriharshita Musunuri
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Cell-free expression (CFE) is an acellular biomanufacturing platform capable of producing diverse biomolecules, including proteins, enzymes, and mRNA, outside of living cells. Unlike traditional bioproduction, which requires sterile culture systems and large-scale bioreactors, CFE enables rapid, modular, and decentralized synthesis. CFE extracts can be freeze-dried, stored for extended periods, and reactivated on demand by simply adding a nucleic acid template. This makes it particularly suited for point-of-need applications such as diagnostics, vaccines, and potentially therapeutics in remote, resource-limited, or emergency settings. However, the same features introduce novel biosecurity concerns. Commercially available CFE kits already support the production of bacteriophages and virus-like particles with minimal specialized equipment. As benchtop DNA synthesis and CFE technologies become increasingly accessible, barriers of skill, facilities, and resources are significantly reduced, enabling malicious actors or small autonomous groups to generate harmful biological agents. To address these risks while enabling safe deployment, we recommend: (1) investing in yield optimization and the development of modular, good manufacturing practice-compatible CFE units for distributed manufacturing (performance and scalability); (2) engineering CFE systems with bioorthogonal or otherwise nontransferable components to reduce potential misuse (intrinsic safety feature); and (3) implementing risk-based restrictions for different CFE formulations, balancing innovation with security oversight (tiered access controls). By combining these measures, CFE can be responsibly integrated into global health security infrastructure, delivering its transformative benefits without compromising biosecurity.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (46)
What it cites, from open citation data, with Crossref's record of each.
Sign in to see 26 more references
A free account opens the rest of the citing papers and references on every paper’s page.